Inovio Pharmaceuticals, Inc.
INO· Nasdaq
INOInovio Pharmaceuticals, Inc.
Filed May 10, 2013 · 10-Q · 40 days after period end · 0001055726-13-000005
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $1.46M | $1.69M | $3.11M |
| Net Income | -$8.84M | -$8.25M | -$2.41M |
| EPS Diluted | -$0.23 | -$0.06 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 10, 2013 · 40 d after period end
